+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GUJTHEM

Gujarat Themis Biosyn Share Price

₹337.90 +13.9 (4.29%)
29.46% Fall from 52W High

26 Oct, 2026 3:31 PM (IST)

Gujarat Themis Biosyn live price: ₹337.90. It opened at ₹321 vs previous close ₹324; intraday high/low: ₹345/₹317. The 50 & 200 DMA stand at ₹382.20/₹370.10.

Gujarat Themis Biosyn Performance

  • Today's Low
  • ₹317
  • Today's High
  • ₹345
  • 52 Week Low
  • ₹225
  • 52 Week High
  • ₹479
  • Open Price₹321
  • Previous Close₹324
  • Volume349,544
  • 50 DMA₹382.20
  • 100 DMA₹379.90
  • 200 DMA₹370.10

Gujarat Themis Biosyn Chart

Investment Returns

  • Over 1 Month -18.97%
  • Over 3 Month -6.27%
  • Over 6 Month -6.12%
  • Over 1 Year -25.32%

Smart Investing Starts Here Start SIP with Gujarat Themis Biosyn for Steady Growth!

Invest Now

Gujarat Themis Biosyn Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 90.3
  • PEG Ratio
  • 9.9
  • Market Cap Cr
  • 4,398
  • P/B Ratio
  • 14.6
  • Average True Range
  • 21.7
  • EPS
  • 3.7
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -15.7
  • RSI
  • 36.88
  • MFI
  • 40.44

Latest Stock News Updates

Gujarat Themis Biosyn Ltd - 506879 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Kindly refer to the RTA compliance Certificate for the quarter ended 30.09.2026.

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please refer to our Scrutinizer Report and Voting Results of 45th Annual General Meeting counter signed by the Chairman.

Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Please refer to our counter signed Scrutinizer''s Report of 45th Annual General Meeting.

Gujarat Themis Biosyn Financials

Gujarat Themis Biosyn Technicals

EMA & SMA

Current Price
₹337.90
+ 13.9 (4.29%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹369.70
  • 50 Day
  • ₹382.20
  • 100 Day
  • ₹379.90
  • 200 Day
  • ₹370.10

Resistance and Support

333.37 Pivot Speed
  • R3 377.20
  • R2 361.10
  • R1 349.50
  • S1 321.80
  • S2 305.70
  • S3 294.10

Gujarat Themis Biosyn Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-10 Others
2026-09-01 Preferential issue of shares
2026-08-07 Quarterly Results
2026-06-19 To consider Fund Raising (Cancelled )
2026-06-06 Fund Raising & Others To consider other business matters.
Date Purpose Remarks
2026-09-23 FINAL Rs.0.67 per share(67%)Final Dividend
2025-09-05 FINAL Rs.0.67 per share(67%)Final Dividend
2024-02-22 INTERIM Rs.0.75 per share(75%)Interim Dividend
2022-12-02 INTERIM Rs.4.40 per share(88%)Interim Dividend
2021-11-25 INTERIM Rs.2.00 per share(40%)Interim Dividend
View Gujarat Themis Biosyn Dividend History Arrow
Date Purpose Remarks
2023-10-10 Split Stock split from Rs. 5/- to Re. 1/-.
Date Purpose Remarks
2024-08-09 Bonus Bonus issue in the ratio of 1:2 of Re. 1/-.

Gujarat Themis Biosyn Shareholding Pattern

59.33%
24.21%
9.63%
3.8%
3.02%

About Gujarat Themis Biosyn

Gujarat Themis Biosyn is principally engaged in the activities pertaining to manufacturing of Bulk Drugs. View More
  • NSE Symbol
  • GUJTHEM
  • BSE Symbol
  • 506879
  • ISIN
  • INE942C01045

Similar Stocks to Gujarat Themis Biosyn

Gujarat Themis Biosyn FAQs

Gujarat Themis Biosyn share price is ₹337 As on 27 October, 2026 | 08:30

The Market Cap of Gujarat Themis Biosyn is ₹4397.8 Cr As on 27 October, 2026 | 08:30

The P/E ratio of Gujarat Themis Biosyn is 90.3 As on 27 October, 2026 | 08:30

The PB ratio of Gujarat Themis Biosyn is 14.6 As on 27 October, 2026 | 08:30

The 52 week High & Low of Gujarat Themis Biosyn is ₹479/₹225 respectively As on 27 October, 2026 | 08:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23